Zhao, R.;                     Liu, J.;                     Li, Z.;                     Zhang, W.;                     Wang, F.;                     Zhang, B.    
        Recent Advances in CXCL12/CXCR4 Antagonists and Nano-Based Drug Delivery Systems for Cancer Therapy. Pharmaceutics 2022, 14, 1541.
    https://doi.org/10.3390/pharmaceutics14081541
    AMA Style
    
                                Zhao R,                                 Liu J,                                 Li Z,                                 Zhang W,                                 Wang F,                                 Zhang B.        
                Recent Advances in CXCL12/CXCR4 Antagonists and Nano-Based Drug Delivery Systems for Cancer Therapy. Pharmaceutics. 2022; 14(8):1541.
        https://doi.org/10.3390/pharmaceutics14081541
    
    Chicago/Turabian Style
    
                                Zhao, Ruogang,                                 Jianhao Liu,                                 Zhaohuan Li,                                 Wenhui Zhang,                                 Feng Wang,                                 and Bo Zhang.        
                2022. "Recent Advances in CXCL12/CXCR4 Antagonists and Nano-Based Drug Delivery Systems for Cancer Therapy" Pharmaceutics 14, no. 8: 1541.
        https://doi.org/10.3390/pharmaceutics14081541
    
    APA Style
    
                                Zhao, R.,                                 Liu, J.,                                 Li, Z.,                                 Zhang, W.,                                 Wang, F.,                                 & Zhang, B.        
        
        (2022). Recent Advances in CXCL12/CXCR4 Antagonists and Nano-Based Drug Delivery Systems for Cancer Therapy. Pharmaceutics, 14(8), 1541.
        https://doi.org/10.3390/pharmaceutics14081541